Skip to main content

Table 2 Five-year relative survival rate, by SEER stage and histologic subtype

From: Changes in ovarian cancer survival during the 20 years before the era of targeted therapy

  2005–2009 (n = 6317) 2010–2014 (n = 7960) p-value
Early stagea 81.5 86.3 <.0001
 Serous carcinoma 77.7 84.1 <.0001
 Mucinous carcinoma 87.6 88.6 0.379
 Endometrioid carcinoma 88.5 93.6 0.047
 Clear cell carcinoma 86.4 87.4 0.673
Distant stage 38.7 43.9 <.0001
 Serous carcinoma 44.1 49.5 <.0001
 Mucinous carcinoma 30.2 31.5 0.247
 Endometrioid carcinoma 50.3 60.1 0.752
 Clear cell carcinoma 38.0 22.5 0.012
  1. SEER Surveillance, Epidemiology, and End Results
  2. aEarly stage: local + regional